Article précédent Article suivant

Mergers in the pharmaceutical sector: An overview of EU and national case law

In the past ten years or so, e-Competitions' Bulletin has regularly reported about pharmaceutical merger control decisions or judgments from various jurisdictions in the world. Many of these cases involved remedies that were meant to address the antitrust concerns that the competent competition authority had identified. The list of reported cases is impressive but not exhaustive. Although merger cases are, by their very nature, facts specific, the present foreword attempts to capture some themes of more general interest. We will refer to a few recent EU cases not covered by the national reports but with these additional references, we do not claim to achieve completeness. Our sole ambition is to flag a couple of themes that the reader might find helpful when reading “the next case”

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

  • Arnold & Porter Kaye Scholer (Brussels)

Citation

Luc Gyselen, Mergers in the pharmaceutical sector : An overview of EU and national case law, 5 mars 2015, e-Competitions Pharma & Mergers, Art. N° 44608

Visites 572

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues